Top Stories

'If you look at technology spending globally, it's not increasing significantly. That means that AI is crowding out other investments,' Lou D’Ambrosio, head of GS Value Accelerator, told PE Hub.

Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for global clinical trials.

'The anticipated shift towards more favorable regulatory conditions, both domestically and at the European level, is expected to support greater economic fluidity,' said Mutares' San Antonio Alonso.

Astorg, BayPine, Blackstone and InTandem Capital Partners are targeting the CRO sector for investments.

Zaorski is moving from Seattle, where Frazier Healthcare is headquartered, to New York to head the firm's new midtown Manhattan office.

The PE firm could fetch $600m-$900m in sale proceeds for FSG.

Checketts and Cynosure’s Spencer Eccles told PE Hub they’re looking to make three to five investments in their recently launched Sports Capital Fund I.

While valuations have been steady, ‘when you were expecting 10 bids, that might be now six or seven,’ says Pfeiffer.

Sources suggested Audax could fetch more than $1.5bn in a sale.

Lightyear, JC Flowers and GTCR are among the PE firms making tracks in the space this year.